Aly Hashim
Family Medicine · Woodstock, GANPI 1700366887
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 99 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $707 and has fallen 56.1% since, to $311 in 2025.
Across 99 payments — averaging $21.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$276
- AstraZeneca$258
- Novo Nordisk$231
- AbbVie$173
- Exact Sciences$154
- GSK$135
- plus $887 from 22 others
What the payments were for
- Food & beverage$2,02196%
- Education$954%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 12 | $276 |
| AstraZeneca | 15 | $258 |
| Novo Nordisk | 13 | $231 |
| AbbVie(2 entities) | 9 | $173 |
| Exact Sciences | 8 | $154 |
| GSK | 8 | $135 |
| Inspire Medical Systems, Inc. | 1 | $117 |
| Astellas Pharma US Inc | 2 | $110 |
| Pfizer | 1 | $101 |
| Johnson & Johnson | 4 | $74 |
| Amgen | 3 | $49 |
| Merck | 3 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $46 |
| E.r. Squibb & Sons, L.L.C. | 2 | $43 |
| Phadia US Inc. | 2 | $36 |
| Boehringer Ingelheim | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Genentech, Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Novartis | 1 | $23 |
| Genentech USA, Inc. | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Surgenex LLC | 1 | $17 |
| Dynavax Technologies Corporation | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Cequr Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,116 in reported general payments places this provider in the 70th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 14 | $7 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Woodstock
- Jeffrey KingsleyColumbus$404K
- Debbie HaginsSavannah$279K
- Yolanda WadeTyrone$233K
- Julian HutchinsWarrenton$222K
- Nadine Halliburton-FosterCumming$219K
- Contessa MetcalfeAtlanta$157K
- Elmore AlexanderStone Mountain$155K
- Bantwal BaligaColumbus$115K
- Avril CampbellFort Benning$108K
- Mitzi RubinMarietta$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.